EcoDrugPlus

Phosphodiesterase 4b

Ensembl ID : ENSMAUG00000018697
Gene Symbol: PDE4B
4 Cross references
295 Possible Orthologues:

Phosphodiesterase 4c, Camp Specific

Ensembl ID : ENSMAUG00000016880
Gene Symbol: PDE4C
1 Cross references
269 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSMAUG00000008303
Gene Symbol: PDE4D
4 Cross references
244 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSMAUG00000000342
Gene Symbol: PDE5A
3 Cross references
220 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSMAUG00000001828
Gene Symbol: PDE7A
4 Cross references
253 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSMAUG00000015483
Gene Symbol: PDE7B
4 Cross references
189 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSMAUG00000001943
Gene Symbol: PDE9A
1 Cross references
280 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSMAUG00000008232
Gene Symbol: PIK3R1
4 Cross references
203 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSMAUG00000016916
Gene Symbol: PIK3R2
2 Cross references
252 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSMAUG00000021154
Gene Symbol: PIK3R2
2 Cross references
252 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSMAUG00000002444
Gene Symbol: PIK3R3
1 Cross references
274 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSMAUG00000020086
Gene Symbol: PIK3R5
4 Cross references
255 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).